Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of gadobutrol vs iodixanol for CT angiography of supraaortal and intracranial vessel stenosis
2007-001796-11Phase 3Terminated
- Sponsor
- Institute for Diagnostic Radiology and Neuroradiology, University Medicine Greifswald
- Start
- Sep 2007
- Modality
- Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of gadobutrol and iodixanol in Supra-aortic trunk stenosis (SATS) and Cerebral atherosclerotic stenosis (ICAD) (2 arms), sponsored by Institute for Diagnostic Radiology and Neuroradiology, University Medicine Greifswald. Primary endpoint: maximum intravascular peak enhancement. Started Sep 2007; status: terminated.
02
Drugs
gadobutroliodixanol
03
Conditions
Supra-aortic trunk stenosis (SATS)Cerebral atherosclerotic stenosis (ICAD)
Beyond the preview
Go deeper on 2007-001796-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001796-11.